Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q1 2012 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
MASIMO CORP | 36 | Q3 2023 | 2.2% |
PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
XENCOR INC | 35 | Q3 2023 | 0.4% |
NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
BIOGEN INC | 31 | Q2 2022 | 3.1% |
CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
3/A | 2024-02-20 |
4/A | 2024-02-20 |
SC 13G/A | 2024-02-20 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-04-07 |
4 | 2023-03-27 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.